Irhythmtech
NASDAQ: IRTCSan Francisco, US · Founded 2006 · Delaware corporation · 1,905 employees on LinkedIn · 4 known investors
Find your way into Irhythmtech
324 people in our graph share verified history with the Irhythmtech team — schools, employers, funds. One of them is your warm intro.
Daniel Demmerunlockedknows Kevin M. King · together at Hewlett Packard Enterprise (overlapped)
×6knows the team · via Hewlett Packard Enterprise
×2knows the team · via Irhythmtech
×3knows the team · via UMass Boston
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
Founders & leadership
KM
Kevin M. KinginBoard Member2012–2022Kevin King is President and CEO of iRhythm, a maker of wearable cardiac monitoring devices and AI-powered diagnostic services. He has led both public and private healthcare companies across genetic analysis, information technology, healthcare services, and medical devices.
SD
Shelly D. GuyerinCFO / Executive Vice President, Finance and Administration2008–2012Shelly D. Guyer is an executive with over 30 years of experience in finance and life sciences, including roles as a venture capitalist and Chief Sustainability Officer, and has held senior positions at companies including Veracyte and Invitae where she managed capital raising and financial strategy.
WF
William F. WillisExecutive
JL
Judith LenaneExecutive
SJ
Steve JohnsoninChief Operating Officer2011–2012Steve Johnson is an executive at iRhythm Technologies with experience in medical device product development, manufacturing, and quality systems for implantable, disposable, and reusable devices. He has led cross-functional teams through clinical trials and market launches of diagnostic and therapeutic medical devices.
Board
TA
JL
Joshua L. GreenBoard director
CD
CE
Chris E. GrantinBoard directorCo-Founder & Chief Operating Officer and Executive Vice President, The Permanente Federation LLC at Kaiser Permanente Ventures
WN
William N. StarlingBoard director
VK
SE
Sam E. BraschBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$49.5M disclosed across 2 rounds · 2011–2014
▶$27.3MraisedMar 2015 · 10 investors · Other Health CareRule 506(b)
▶$27.3MraisedMar 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin M. KingExecutive Officer, Director
- Tiba AynechiDirector
- Joshua L. GreenDirector
- Casper de ClercqDirector
- Chris E. GrantDirector
- William N. StarlingDirector
- Raymond ScottDirector
- Vijay K. LathiDirector
- Offering amount
- $29.5M
- Amount sold
- $27.3M
- Minimum investment
- $1
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.1MraisedJan 2012 · 10 investors · Other Health CareRule 506(b)
▶$22.1MraisedJan 2012 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roberta R. KatzDirector
- Shelly D. GuyerExecutive Officer
- William N. StarlingDirector
- William F. WillisExecutive Officer, Director
- Sam E. BraschDirector
- Joshua L. GreenDirector
- R. Hardwin MeadDirector
- Judith LenaneExecutive Officer
- Steve JohnsonExecutive Officer
- Vijay K. LathiDirector
- Offering amount
- $22.1M
- Amount sold
- $22.1M
- First sale
- Apr 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$359.1Mvaluation at IPOOct 2016 · $17.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
3 people who came through Irhythmtech went on to found or lead other companies.
Competitors · 2
by search overlap
Rf Surgical359 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific276 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies competing with Irhythmtech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Irhythmtech do?
- iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
- Who are Irhythmtech's investors?
- Irhythmtech's investors include Kaiser Permanente Ventures, Norwest Venture Partners, New Leaf Venture Partners, St. Jude Medical.
- How much funding has Irhythmtech raised?
- Irhythmtech has disclosed $49.5M raised across 2 rounds.
- Where is Irhythmtech headquartered?
- Irhythmtech is headquartered in San Francisco, US.